| 2935.00.75 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 57.5% |
| 2936 | | XI. PROVITAMINS, VITAMINS AND HORMONES | | | | |
| 2936.21.00 | 00 | Vitamins A and their derivatives | kg | Free | | 25% |
| 2936.22.00 | 00 | Vitamin B1 (Thiamine) and its derivatives | kg | Free | | 25% |
| 2936.23.00 | 00 | Vitamin B2 (Riboflavin) and its derivatives | kg | Free | | 15.4￠/kg + 62% |
| 2936.24.00 | 00 | D- or DL-Pantothenic acid (Vitamin B3 or Vitamin B5) and its derivatives | kg | Free | | 25% |
| 2936.25.00 | 00 | Vitamin B6 (Pyridoxine and related compounds with Vitamin B6 activity) and its derivatives | kg | Free | | 25% |
| 2936.26.00 | 00 | Vitamin B12 (Cyanocobalamin and related compounds with Vitamin B12 activity) and its derivatives | kg | Free | | 15.4￠/kg + 145.5% |
| 2936.27.00 | 00 | Vitamin C (Ascorbic acid) and its derivatives | kg | Free | | 25% |
| 2936.28.00 | 00 | Vitamin E (Tocopherols and related compounds with Vitamin E activity) and its derivatives | kg | Free | | 15.4￠/kg + 63.5% |
| 2936.29.15 | | Niacin and niacinamide | | Free | | 25% |
| 2936.29.15 | 30 | Niacinamide | kg | | | |
| 2936.29.15 | 10 | Pharmaceutical grade | kg | | | |
| 2936.29.50 | 20 | Vitamins D and their derivatives | kg | | | |
| 2936.90.01 | | Other, including proviatmins and natural concentrates | | Free | | 25% |
| 2936.90.01 | 10 | Provitamins | kg | | | |
| 2937.11.00 | 00 | Somatotropin, its derivatives and structural analogues | g | Free | | 10% |
| 2937.12.00 | 00 | Insulin and its salts | g | Free | | 10% |
| 2937.21.00 | 10 | Cortisone | g | | | |
| 2937.21.00 | 20 | Hydrocortisone | g | | | |
| 2937.21.00 | 30 | Prednisone | g | | | |
| 2937.21.00 | 40 | Prednisolone | g | | | |
| 2937.22.00 | 00 | Halogenated derivatives of adrenal cortical hormones | g | Free | | 25% |
| 2937.23.10 | | Obtained directly or indirectly from animal or vegetable materials | | Free | | 25% |
| 2937.23.10 | 10 | Estrogens | g | | | |
